Reactogenicity and Protectivity Following Measles- Rubella (MR) Routine Immunization in Indonesian Infants and Children
Clinical trial NCT03680417 · COMPLETED
Trial details
- NCT number
- NCT03680417
- Sponsor
- PT Bio Farma
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-16
- Primary completion
- 2018-02-26
- Enrollment
- 590
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.